Hepatitis B surface antigen- and immunoglobulin-specific circulating immune complexes in acute hepatitis B virus infection

Clinical Immunology and Immunopathology

Volumn 80, Issue 3 II, 1996, Pages 278-282

  Tsai, Jung Fa ^a   Margolis, Harold S ^c   Jeng, Jen Eing ^a   Mei Shang, Ho ^b   Chang, Wen Yu ^a   Hsieh, Min Yuh ^a   Lin, Zu Yau ^a   Tsai, Juei Hsiung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M;

ACUTE HEPATITIS; ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY COMPLEX; EPITOPES; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; MALE;

EID: 0029795783     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0124     Document Type: Article

References (40)

1. Hoofnagle, J. H., Hepatitis B. In "Bokus Gastroenterology" (W. S. Haubrich, F. Schaffner, and J. E. Berk, Eds.), 5th ed., pp. 2062-2081, Saunders, Philadelphia, 1995.
2. Tsai, J. F., Chang, W. Y., Jeng, J. E., Ho., M. S., Wang, L. Y., Hsieh, M. Y., Chen, S. C., Chuang, W. L., Lin, Z. Y., and Tsai, J. H., Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J. Med. Virol. 41, 296-300, 1993.
3. Tsai, J. F., Chang, W. Y., Jeng, J. E., Ho, M. S., Lin, Z. Y., and Tsai, J. H., Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: A casecontrol study. Liver 14, 98-102, 1994.
4. Tsai, J. F., Chang, W. Y., Jeng, J. E., Ho, M. S., Lin, Z. Y., and Tsai, J. H., Frequency of raised α-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. Er. J. Cancer 69, 1157-1159, 1994.
5. Tsai, J. F., Jeng, J. E., Chang, W. Y., Lin, Z. Y., and Tsai, J. H., Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B. Scand. J. Gastroenterol. 29, 550-552, 1994.
6. Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Lin, Z. Y., and Tsai, J. H., Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: A case-control study. Int. J. Cancer 56, 619-621, 1994.
7. Tsai, J. F., Chang, W. Y., Jeng, J. E., Ho, M. S., Lin, Z. Y., and Tsai, J. H., Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J. Med. Virol. 44, 9295, 1994.
8. Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Lin, Z. Y., and Tsai, J. H., Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J. Hepatol. 24, 271-276, 1996.
9. Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., and Tsai, J. H., Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Br. J. Cancer, in press, 1996.
10. Paroli, M., Franco, A., De Petrillo, G., Benvenuto, R., and Barnaba, V., Cellular immune reactions to hepatitis B envelope anti-gens. In "Immunology and Liver" (K. H. meyer zum Buschenfelde, J. H. Hoofnagle, and M. Manns, Eds.), pp. 48-51, Kluwer Academic, Dordrecht, 1993.
11. Moriyama, T., Guilhot, S., Klopchin, K., Moss, B., Pinkert, C. A., Palmiter, R. D., Brinster, R. L., Kanagawa, O., and Chisari, S. V., Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248, 361-364, 1990.
12. Barnaba, V., Franco, A., Alberti, A., Balsano, C., Benvenuto, R., and Balsano, F., Recognition of hepatitis B virus envelope by liver infiltrating T lymphocytes in chronic HBV infection. J. Immunol. 143, 2650-2655, 1989.
13. Celie, E., and Chang, T. W., HBsAg-serum protein complexes stimulate immune T lymphocytes more efficiently than do pure HBsAg. Hepatology 4, 1116-1123, 1984.
14. Casali, P., and Oldstone, M. B. A., Immune complexes in viral infection. Curr. Top. Microbiol. Immunol. 104, 7-48, 1983.
15. Tsai, J. F., Margolis, H. S., Fields, H. A., Nainan, O. V., Chang, W. Y., and Tsai, J. H., Immunoglobulin and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis with hepatitis delta virus infection. J. Med. Virol. 30, 25-29, 1990.
16. Tsai, J. F., Tsai, J. H., and Chang, W. Y., Relationship of serum α-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Gastroenterol. Jpn. 25, 388-393, 1990.
17. Tsai, J. F., Tsai, J. H., Chang, W. Y., and Tong, T. C., Elevation of circulating immune complexes and its relationship to α-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Cancer Invest. 9, 137-143, 1991.
18. Tsai, J. F., Margolis, H. S., Jeng, J. E., Ho, M. S., Chang, W. Y., Lin, Z. Y., and Tsai, J. H., Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection. Clin. Immunol. Immunopathol. 75, 39-44, 1995.
19. Tsai, J. F., Jeng, J. E., Chang, W. Y., Ho, M. S., Lin, Z. Y., and Tsai, J. H., Increased IgM-containing circulating immune complexes in patients co-infected with hepatitis C and hepatitis B. Medicine 74, 136-143, 1995.
20. Tsai, J. F., Jeng, J. E., Chang, W. Y., Ho, M. S., Lin, Z. Y., and Tsai, J. H., Circulating immune complexes in chronic hepatitis C. J. Med. Virol. 46, 12-17, 1995.
21. Tsai, J. F., Jeng, J. E., Chang, W. Y., Ho, M. S., Lin, Z. Y., and Tsai, J. H., Clinical evaluation of serum α-fetoprotein and circulating immune complexes as tumor markers of hepatocellular carcinoma. Er. J. Cancer 72, 442-446, 1995.
22. Margolis, H. S., Nanian, O. V., Fields, H. A., and Bradley, D. W., Characteristics of chemically aggregated IgM in an immunoglobulin class-specific immune complex assay. J. Immunol. Methods 102, 23-31, 1987.
23. Abrass, C. K., Border, W. A., and Hepner, G., Nonspecificity of circulating immune complexes in patients with acute and chronic liver diseases. Clin. Exp. Immunol. 40, 292-298, 1980.
24. Brown, S. E., Steward, M. W., Viola, L., Howard, C. R., and Murry-Lyon, I. M., Chronic liver disease: The detection and characterization of circulating immune complexes. Immunology 49, 673-683, 1983.
25. Jones, V. E., and Orlans, E., Isolation of immune complexes and characteristics of their constituent antigens and antibodies in some human diseases: A review. J. Immunol. Methods 44, 249-270, 1981.
26. Tsai, J. F., Margolis, H. S., Jeng, J. E., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., and Tsai, J. H., Increased IgM class circulating immune complexes in acute hepatitis A virus infection. Clin. Immunol. Immunopathol. 78, 291-295, 1996.
27. Ackerman, Z., Wands, J. R., Gazitt, Y., Brechet, C., Kew, M. C., and Shouval, D., Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. J. Hepatol. 20, 398-404, 1994.
28. Stransky, J., Vodak, M., and Zichova, M., Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B. Acta Virol. 37, 170-174, 1993.
29. Milner, L. S., Houser, M. T., Kolbeck, P. C., Antonson, D. L., McDonald, T. L., Markin, R. S., and Shaw, B. W., Glomerular injury in end-stage liver disease - Role of circulating IgG and IgM immune complexes. Pediatr. Nephrol. 7, 6-10, 1993.
30. Ljunggren, K., Hansson, B. G., and Nordenfelt, E., HBsAg/IgM complexes as a prognostic marker of chronicity in acute hepatitis B virus infection. Scand. J. Infect. Dis. 23, 529-534, 1991.
31. Grangeot-Keros, L., Pelletier, G., Briantais, M. J., and Pillot, J., Prognostic value of HBsAg/IgM complexes in hepatitis B patients: Nature of the proteins involved. J. Med. Virol. 25, 309-315, 1988.
32. Francis, D. P., Hadler, S. C., Prendergast, T. J., Peterson, E., Ginsberg, M. M., Lookabaugh, C., Holmes, J. R., and Maynard, J. E., Occurrence of hepatitis A, B and Non-A/Non-B in the United States. CDC Sentinel County Hepatitis Study. Am. J. Med. 76, 69-74, 1984.
33. Mannik, M., Hackenstak, A. O., and Arend, W. P., The fate and detection of circulating immune complexes. Prog. Immunol. 5, 91-101, 1974.
34. Veerhuis, R., Krol, M. C., van Es, L. A., and Daha, M. R., Difference in clearance kinetics of particulate immune complexes and soluble aggregates of IgG in vivo. Clin. Immunol. Immunopathol. 41, 379-391, 1986.
35. Basson, J., Tardy, J. C., and Aymard, M., Characterization of immune complexes containing cytomegalovirus-specific IgM antibodies following a kidney graft. J. Med. Virol. 33, 205-210, 1991.
36. Quiroga, J. N., Campillo, M. L., Catillo, L., Bartolome, J., Porres, J. C., and Carreno, V., IgM antibody to hepatitis C virus in acute and chronic hepatitis C. Hepatology 14, 38-43, 1991.
37. Troisi, C. L., and Hollinger, F. B., Detection of an IgM antiidiotype directed against anti-HBs in hepatitis B patients. Hepatology 5, 758-762, 1985.
38. Roitt, I. M., Brostoff, J., and Male, D. K (Eds.), "Immunology," pp. 10.2-10.3, Blackwell Sci., Oxford, 1985.
39. Stanworth, D. R., and Turner, M. W., Immunochemical analysis of human and rabbit immunoglobulins and their subunits. In "Handbook of Experimental Immunology: Vol. 1: Immunochemistry" (D. M. Weir, Ed.), 4th ed., pp. 12.1-12.46, Blackwell Sci., Oxford, 1985.
40. Devy, M. E., Taylor, J., and Steward, M. W., Measurement of antigen-antibody complexes in mouse sera by conglutinin, C1q and rheumatoid factor solid phase binding assays. J. Immunol. Methods 34, 191-203, 1980.